AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer	Abdominal Neoplasms, Adnexal Diseases, Carcinoma, Ovarian Epithelial, Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Peritoneal Diseases, Recurrence, Urogenital Diseases, Urogenital Neoplasms, carcinoma, endocrine system disorder, epithelial neoplasm, fallopian tube disorder, fallopian tube neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, peritoneal neoplasm	Active, not recruiting	Phase 1	2026-09-03		NCT05617755

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Arsenal Biosciences, Inc.	3

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Barbara Ann Karmanos Cancer Institute	Detroit	United States	44
MD Anderson Cancer Center	Houston	United States	589
Memorial Sloan Kettering Cancer Center	New York	United States	1000
Roswell Park Comprehensive Cancer Center	Buffalo	United States	32
U of Colorado Cancer Center - Anschutz Medical Campus	Aurora	United States	1
U of Iowa Health Care	Iowa City	United States	1
U of Washington - Fred Hutchinson Cancer Center	Seattle	United States	1
UCSF Helen Diller Family Comprehensive Cancer Center	San Francisco	United States	22